WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'7501 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 6'5511 Child (under 5 years) mortality rate: 352

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 800  795  791  786  781  744  725  777 
Births 16  16  17  17  17  16  17  23 
Surviving infants 16  16  16  16  17  16  16  21 
Pop. less than 5 years 84  89  93  98  99  87  85  119 
Pop. less than 15 years 289  292  294  295  291  263  250  330 
Female 15-49 years 203  202  201  200  199  193  198  185 

Number of reported case

(Click for retrospective incidence data for Guyana)
Diphtheria
Japanese encephalitis
Measles 464 
Mumps
Pertussis 61 
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal) 1'010 
Tetanus (total) 1'010  20 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guyana)
Vaccine year result method % card seen                                                
BCG 2007  94  DHS   88  98  98  97  98  98  93  85  68 
DTP1 2007  92  DHS   88  98  99  92  100  97  97 
DTP3 2007  85  DHS   88  98  97  93  95  98  88  82  36 
HepB_BD         
HepB3 2007  85  DHS   88  98  97  93  95  98 
Hib3 2007  85  DHS   88  98  97  93  95  98 
JapEnc         
MCV 2007  82  DHS   88  100  99  98  95  97  86  73 
MCV2          95  90  84  82  84 
PCV1          98  94  78 
PCV3          96  90  50 
Pol3 2007  70  DHS   88  98  97  93  95  97  79  79  42 
Rota1          97  95  82  70 
Rota_last          94  91  77  38 
Rubella1          100  99  98  95  97 
TT2plus 1999  61  MICS   89  99  95  97  97  97  81 
PAB         
VAD1         
YFV 2007  79  DHS   88  100  99  97  95  97  83 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guyana)
BCG 98  98  97  98  98  93  85  68 
DTP1 98  99  97  99  99  97  94  60 
DTP3 98  97  93  95  98  88  83  35 
HepB3 98  97  93  95  98 
HepB_BD
Hib3 98  97  93  95  98 
MCV 99  99  98  95  97  86  73 
MCV2 95  90  84  82  84 
PAB 90  90  90  97  90  82  56 
PCV3 96  90  50 
Pol3 98  97  93  95  97  79  79  42 
Rota_last 94  91  77  39 
YFV 99  99  97  94  97  83 

Number of districts in the country 13  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 77
From 80 to 89% 23
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 2 months; Yes
DTwPHibHep 2, 4, 6 months; Yes
HIB 2, 4, 6 months; Yes
HPV 1st contact; +1, +6 months; special groups
HepB +1, +5 months; Yes adults
IPV 2, 4, 6, 18 months; 3 years; No special groups
MMR 12 months; 3 years and 9 months; Yes
MenACW special groups
OPV 2, 4, 6, 18 months; 3 years; Yes
Pneumo_conj 2, 4, 6 months; Yes
Pneumo_ps No
Rotavirus 2, 4, 6 months; Yes
Td 15 years; Yes
YF 12 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2006-2015  2006-2015  2006-2015  2008-2015  2007-2012  2007-2012  2007-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 13  13  13  13  13  13  13 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  No       

System performance

Total Nº districts in country number 13  13  13  13  13  13  13 
Nº districts with DTP3 coverage >=80% number 13  12  12  13  13 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  92  92  100  100  31 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 62  69  62    62  62   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 61  57  54  100  100  97  100 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.